U.S. Oil and Gas Stock News

NYSE:ARES
NYSE:ARESCapital Markets

A Look At Ares Management (ARES) Valuation After The US$910m Student Housing Joint Venture

Ares Management (ARES) is in focus after partnering with The Scion Group in a joint venture to acquire a 12 property, 7,578 bed student housing portfolio for about US$910 million. See our latest analysis for Ares Management. The Ares Management share price has risen 8.6% over the past 90 days, including an 8.0% 30 day share price return, yet is still down 25.2% year to date, while the 5 year total shareholder return of 163.1% points to strong longer term performance momentum. If deals like...
NYSE:ELV
NYSE:ELVHealthcare

A Look At Elevance Health (ELV) Valuation As Raised EPS Guidance Follows Robust Earnings Growth

Elevance Health (ELV) is back in focus after first quarter 2026 results showed adjusted EPS of $12.58, a 5.1% year-over-year increase, and management raised full year adjusted EPS guidance. See our latest analysis for Elevance Health. The first quarter numbers and guidance upgrade have coincided with stronger momentum in the stock, with a 14.5% 1 month share price return and 17.5% 3 month share price return, while the 3 year total shareholder return is still lower. If Elevance Health’s move...
NasdaqGM:CAMT
NasdaqGM:CAMTSemiconductor

Camtek (NasdaqGM:CAMT) Valuation Check After Recent Share Price Pullback And Strong Longer Term Gains

Camtek stock snapshot after recent trading move Camtek (NasdaqGM:CAMT) has drawn fresh attention after a recent trading move, with the stock last closing at US$167.37. For context, the share price is down about 18% over the past month but up roughly 9% in the past 3 months. See our latest analysis for Camtek. Despite the 1 month share price return declining 17.6%, Camtek’s year to date share price return of 44.9% and a very large 1 year total shareholder return suggest longer term momentum...
NYSE:BE
NYSE:BEElectrical

Bloom Energy (BE) Is Up 9.6% After Securing 328 MW AI Data Center Fuel Cell Deal

Earlier this week, Nebius and Bloom Energy announced a long-term agreement for Bloom to deploy 328 MW of behind-the-meter fuel cell capacity to power Nebius’s AI data centers, with the deal potentially delivering up to US$2.60 billion in energy service fees over ten years. The partnership not only replaces the need for gas turbines at the first site but also showcases how Bloom’s modular, fast-to-deploy fuel cells can address grid bottlenecks as AI operators seek cleaner, high-performance...
NasdaqGS:ALRM
NasdaqGS:ALRMSoftware

How Investors Are Reacting To Alarm.com (ALRM) Softer Demand And Questions Around Recurring Software Profitability

In recent months, Alarm.com Holdings has reported slowing revenue growth, flat operating margins, and weaker billing trends, which together indicate softer underlying demand and rising competitive pressure in its markets. These billing and margin pressures matter because they touch the core of Alarm.com’s recurring software model, raising fresh questions about how effectively the company can convert its installed base and technology investments into sustained profitability over time. We’ll...
NYSE:DOLE
NYSE:DOLEFood

A Look At Dole (DOLE) Valuation As Q1 Revenue Grows And Automation And AI Investments Are Announced

Dole (DOLE) is back in focus after its Q1 2026 update, which combined solid revenue growth, higher costs, fresh investment plans in automation and AI, and an active hunt for European bolt-on acquisitions. See our latest analysis for Dole. The stock has had a mixed run, with the share price down 8.67% over the past 90 days and 4.56% over the past month, while the 1 year total shareholder return is 5.65%. This suggests that recent momentum has cooled despite a modest longer term gain. If Dole’s...
NasdaqCM:AHG
NasdaqCM:AHGHealthcare

What Does Akso Health (AHG)'s Auditor Switch Reveal About Its Governance And Transparency Priorities?

On May 12, 2026, Akso Health Group’s audit committee dismissed Onestop Assurance PAC as its independent registered public accounting firm and appointed CHI-LLTC as the new auditor, effective immediately. This change in external auditor highlights a meaningful shift in Akso Health Group’s approach to financial oversight and corporate governance transparency. We will now examine how the shift from Onestop Assurance PAC to CHI-LLTC may influence Akso Health Group’s investment narrative. Invest...
NasdaqGS:SBUX
NasdaqGS:SBUXHospitality

A Look At Starbucks (SBUX) Valuation After Recent Short Term Share Price Weakness

Starbucks (SBUX) stock has been on investors’ radar after recent trading pulled it lower over the past week, even as returns over the past month and past 3 months remain in positive territory. See our latest analysis for Starbucks. The recent 1 day share price decline of 0.98% and 7 day share price drop of 3.47% sit against a stronger backdrop, with a 30 day share price return of 4.50%, a 90 day share price return of 8.79%, and a 1 year total shareholder return of 25.39%. This suggests...
NYSE:BV
NYSE:BVCommercial Services

A Look At BrightView Holdings (BV) Valuation After Revenue Beat And Cautious Earnings Guidance

BrightView earnings reaction and what it means for investors BrightView Holdings (BV) recently reported Q1 revenue growth of 6.1% year on year, topping analyst expectations by 8.9%, while adjusted operating income lagged estimates and full-year guidance came in weaker than peers. Even so, the stock has risen 5% since the release. This suggests that investors are currently putting more weight on the revenue outperformance than on the profitability shortfall or softer outlook. See our latest...
NYSE:SLGN
NYSE:SLGNPackaging

Does Silgan’s Maintained Dividend Amid Tight Margins Reframe Its Capital Allocation Story For SLGN?

Earlier this month, Silgan Holdings Inc.’s Board of Directors declared a quarterly cash dividend of US$0.21 per share, payable on June 15, 2026 to shareholders of record on June 1, 2026. This dividend decision highlights management’s commitment to ongoing cash returns even as the company contends with high production costs and constrained free cash flow. Next, we’ll examine how maintaining this dividend amid tight margins could influence Silgan Holdings’ investment narrative and future...
NasdaqGS:EEFT
NasdaqGS:EEFTDiversified Financial

How Investors May Respond To Euronet Worldwide (EEFT) Digital-First Pivot And Capital Return Shift

Euronet Worldwide recently reported a strong first quarter, with US$1.01 billion in revenue exceeding analyst expectations and underscoring progress across its global payments and money transfer operations. At its May 20, 2026 Investor Day, the company outlined a shift toward a unified global payments platform emphasizing digital channels, shared technology, and increased capital allocation to buybacks and acquisitions. Now we will explore how Euronet’s digital-first repositioning and...
NasdaqGS:UNIT
NasdaqGS:UNITTelecom

A Look At Uniti Group (UNIT) Valuation After Mixed Share Price Performance

Recent performance snapshot Uniti Group (UNIT) has drawn fresh attention after a mixed run in the stock, with the price around $11.04 and recent returns ranging from a decline over the past month to gains over the past 3 months and year to date. See our latest analysis for Uniti Group. The share price has cooled in the past month, down 7.85%, but that comes after a strong 90 day share price return of 36.97% and a 3 year total shareholder return of 115.83%. This suggests momentum has been...
NYSE:SITE
NYSE:SITETrade Distributors

Is SiteOne’s Weaker Q1 Results Reframing the Investment Case for SiteOne Landscape Supply (SITE)?

Earlier in 2026, SiteOne Landscape Supply held its annual meeting, where shareholders elected William W. Douglas III and Jeri L. Isbell to one-year board terms, ratified Deloitte & Touche LLP as auditor for the 2026 fiscal year, and approved the advisory vote on executive compensation. On the same day, SiteOne reported first-quarter 2026 results that included a net loss and revenue below expectations, a combination that sharpened investor attention on how effectively its growth and margin...
NYSE:KOS
NYSE:KOSOil and Gas

A Look At Kosmos Energy (KOS) Valuation As Record Output And Higher Guidance Draw Investor Interest

Kosmos Energy (KOS) recently reported record quarterly and daily production, updated its full year production growth outlook, and set a higher debt reduction target, drawing fresh attention to the stock’s risk and reward profile. See our latest analysis for Kosmos Energy. The stock’s recent 1-day and 7-day share price returns, down 2.9% and 6.2%, contrast with a 30-day share price return of 7.8% and a 90-day gain of 47.1%. The 239.4% year to date share price return and mixed longer term total...
NYSE:MTZ
NYSE:MTZConstruction

A Look At MasTec (MTZ) Valuation As AI Data Center And Backlog Growth Drive Investor Interest

Recent commentary around MasTec (MTZ) focuses on its strong sales pipeline, expectations for faster sales growth, and earnings per share that exceeded peers, along with fund interest related to AI-capable data center infrastructure spending. See our latest analysis for MasTec. Despite a recent pullback, with the 7 day share price return down 7.9% and the 1 day share price return down 1.7%, MasTec’s 90 day share price return of 37.2% and 1 year total shareholder return of 150.7% point to...
NasdaqGS:CGON
NasdaqGS:CGONBiotechs

How Investors Are Reacting To CG Oncology (CGON) Phase 2 Data In Community Bladder Cancer Settings

CG Oncology recently reported positive first results from its Phase 2 CORE-008 Cohort CX trial, showing encouraging high-grade event-free survival, high complete response rates, and a favorable safety profile for intravesical cretostimogene grenadenorepvec plus gemcitabine in high-risk BCG-exposed or BCG-unresponsive non-muscle invasive bladder cancer, with data presented at the 2026 AUA meeting. An interesting aspect is that more than 80% of patients were treated in community practices,...
NasdaqGS:NVDA
NasdaqGS:NVDASemiconductor

Assessing Nvidia (NVDA) Valuation After Record Results Dividend Hike And US$80b Buyback

NVIDIA (NVDA) just reported record quarterly results, paired with a 25x dividend increase to US$0.25 per share and a new US$80b buyback. This puts capital returns and AI growth firmly in focus for shareholders. See our latest analysis for NVIDIA. Despite a slight pullback around the results, with the share price down 1.9% over the last day and 4.4% over the past week, NVIDIA still shows firm momentum, with a 30 day share price return of 3.4% and a 1 year total shareholder return of 64.1% on...
NYSE:NCLH
NYSE:NCLHHospitality

Norwegian Cruise Line (NCLH) Is Up 5.0% After Beat, Cost Cuts, Activist Deal And Insider Buys

Norwegian Cruise Line Holdings recently reported first-quarter results that exceeded its own guidance and consensus estimates, outlined US$125 million in SG&A run-rate savings, and entered a cooperation agreement with activist investor Elliott Management that reshaped its board and governance oversight. At the same time, directors Jonathan Z. Cohen and Jose E. Cil purchased tens of thousands of shares on the open market, even as a law firm announced an investigation into potential...
NasdaqGS:HWC
NasdaqGS:HWCBanks

Why Hancock Whitney (HWC) Is Up 5.2% After Q1 Earnings Beat And 2026 Outlook Update

In the past quarter, Hancock Whitney reported first-quarter 2026 adjusted earnings per share of US$1.52, ahead of expectations, as higher net interest income and modest loan growth helped offset a restructuring loss in its securities portfolio and a drop in non-interest income. Alongside these results, management outlined a 2026 outlook calling for modest growth in loans, deposits, and net interest income, while also filing a Form 144 for proposed insider share sales tied to 2020 stock...
NasdaqGM:EYPT
NasdaqGM:EYPTPharmaceuticals

A Look At EyePoint (EYPT) Valuation As DURAVYU Phase 3 Safety Review Keeps Trials On Track

The latest review by the independent Data Safety Monitoring Committee of EyePoint (EYPT) pivotal Phase 3 DURAVYU program kept both LUGANO and LUCIA trials on course, with interim masked data indicating a continued favorable safety profile. See our latest analysis for EyePoint. EyePoint’s recent safety update for DURAVYU comes after a sharp share price pullback this year, with the stock down 26.03% on a year to date share price return but still showing a 127.64% total shareholder return over...
NasdaqGS:FSLY
NasdaqGS:FSLYIT

Will AI-Fueled Edge Growth and Insider Sales Shift Fastly's (FSLY) Investment Narrative?

Fastly recently reported strong growth in its Compute and Observability business, highlighting surging demand for AI-powered workloads at the edge and expanded customer co-innovation on complex use cases. A series of insider share sales in recent months, largely tied to tax obligations and pre-arranged trading plans, underscores that recent management transactions appear compensation-related rather than signaling operational change. Next, we’ll examine how Fastly’s accelerating AI-driven...
NasdaqCM:NGEN
NasdaqCM:NGENPharmaceuticals

Assessing NervGen Pharma (NasdaqCM:NGEN) Valuation After Its $60 Million Follow On Equity Offering

NervGen Pharma (NGEN) has drawn fresh attention after completing a follow on public equity offering of approximately $60 million, including common shares and warrants, to fund its neuroreparative drug development programs. See our latest analysis for NervGen Pharma. The follow on offering has coincided with sharp share price pressure, with NervGen Pharma’s 1 day share price return down 43.48% and its year to date share price return down 64.63%. This comes even though the 5 year total...